Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€41.55

€41.55

-0.730%
-0.3
-0.730%
€0.000

€0.000

 
17.09.24 / Tradegate WKN: STRA55 / Name: Stratec / Stock / Healthcare Equipment & Supplies / Small Cap /
Latest predictions
€0.000
27.08.24
-5.46%
buy
30.11.23
6.05%
buy
24.07.23
-17.45%
buy
Your prediction

Stratec SE Stock

Stratec SE shows a slight decrease today, losing -€0.300 (-0.730%) compared to yesterday.
Our community is currently high on Stratec SE with 3 Buy predictions and 0 Sell predictions.
Our community identified positive and negative aspects for Stratec SE stock for the coming years. 1 users see the criterium "Unique positioning" as a plus for the Stratec SE stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Stratec SE in the next few years

Pros
?
B****
?
S********** s********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Stratec SE vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Stratec SE -0.730% 3.358% -2.807% -12.156% -9.477% -69.848% -39.870%
Paul Hartmann AG -0.500% 1.015% 1.531% -5.238% -2.927% -45.777% -32.770%
Eckert & Ziegler Strahlen- und Medizintechnik AG -0.430% 2.960% -3.736% 33.696% 0.968% -67.186% 7.439%
Geratherm Medical AG 10.100% -12.775% 1.538% -38.125% -27.339% -57.419% -49.554%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

The financials of Stratec, a company operating in the Healthcare Equipment & Supplies industry, present a mixed picture. On one hand, the firm exhibits solid revenue generation capabilities and figures that suggest a growing market presence. On the other hand, certain financial metrics raise concerns about its profit margins and growth potential. A careful examination of the balance sheet, cash flow statements, income statements, and financial ratios reveals both strengths and weaknesses.

*Pros: *

Strong Revenue Generation: Stratec reported a total revenue of €261.91 million in 2023, with a consistent upward trend observed over the previous years. This reflects the company’s capacity to capture market share and expand its operations in a growing healthcare sector.

Comments

systinvest bought the security Stratec SE in his wikifolio Aktienwertselektion mit System.
Show more

Prediction Buy
Perf. (%) 30.79%
Target price 53.240
Change
Ends at 08.04.19

(Laufzeit überschritten)
Show more

Prediction Buy
Perf. (%) 30.79%
Target price 53.240
Change
Ends at 08.04.19

(Laufzeit überschritten)
Show more

News

EQS-News: STRATEC POSTS RESULTS FOR FIRST HALF OF 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
EQS-News: STRATEC POSTS RESULTS FOR FIRST HALF OF 2024
EQS-News: STRATEC POSTS RESULTS FOR FIRST HALF OF 2024
EQS-News: STRATEC REPORTS CHANGES IN FINANCE DIVISION: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
EQS-News: STRATEC REPORTS CHANGES IN FINANCE DIVISION
EQS-News: STRATEC REPORTS CHANGES IN FINANCE DIVISION
EQS-News: STRATEC ANNUAL GENERAL MEETING ADOPTS RESOLUTION ON DIVIDEND AND APPROVES ALL AGENDA ITEMS: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
EQS-News: STRATEC ANNUAL GENERAL MEETING ADOPTS RESOLUTION ON DIVIDEND AND APPROVES ALL AGENDA ITEMS
EQS-News: STRATEC ANNUAL GENERAL MEETING ADOPTS RESOLUTION ON DIVIDEND AND APPROVES ALL AGENDA ITEMS